代表性科研项目：

1、《呼吸机相关肺内微环境的演变诱导肺血管内皮细胞损伤致ARDS肺动脉高压的机制研究》，国家自然科学基金；《突发急性重症呼吸道传染病救治新技术和新方案研究》子课题三子任务二《广东省呼吸支持规范化治疗研究》，科技部-国家科技重大专项；《体外膜肺（ECMO）救治重症新冠肺炎的应用指征探索》，广东省科技厅；《探讨不同驱动压通过Piezo1促进ARDS相关肺动脉高压的机制与治疗手段》，广州市科技局。

代表性学术论文：

1、Xu Y, Xu Z, Liu X, et al. Clinical findings of COVID-19 patients admitted to intensive care units in Guangdong Province, China: a multicenter, retrospective, observational study. Front Med 2020;7:576457. 

2、Zhang R, Xu Y, Sang L, Chen S, Huang Y, Nong L, et al. Factors associated with intraoperative extracorporeal membrane oxygenation support during lung transplantation. Respir Res. 2020;21(1):85.

3、Li Y, Hou G, Zhou H, Wang Y, Tun HM, Zhu A, Zhao J, Xiao F, Lin S, Liu D, Zhou D, Mai L, Zhang L, Zhang Z, Kuang L, Guan J, Chen Q, Wen L, Zhang Y, Zhuo J, Li F, Zhuang Z, Chen Z, Luo L, Liu D, Chen C, Gan M, Zhong N, Zhao J, Ren Y, Xu Y. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery. Signal Transduct Target Ther. 2021;6(1):155.

4、Wang D, Wang Y, Sun W, Zhang L, Ji J, Zhang Z, Cheng X, Li Y, Xiao F, Zhu A, Zhong B, Ruan S, Li J, Ren P, Ou Z, Xiao M, Li M, Deng Z, Zhong H, Li F, Wang WJ, Zhang Y, Chen W, Zhu S, Xu X, Jin X, Zhao J, Zhong N, Zhang W, Zhao J, Li J, Xu Y. Population bottlenecks and intra-host evolution during human-to-human transmission of SARS-CoV-2. Front. Med. 2021;8:585358. 

5、Xu Y, Li M, Zhou L, et al. Ribavirin treatment for critically ill COVID‐19 patients: an observational study. Infect Drug Resist. 2021;14:5287‐5291.

6、Xiao F, Sun J, Xu Y, Li F, Huang X, Li H, Zhao J, Huang J, Zhao J. Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg Infect Dis. 2020;26(8):1920–1922.